The Enterprise Value as of November 2024 (TTM) for Chinook Therapeutics, Inc. (KDNY) is 2.63B

According to Chinook Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 2.63B. This represents a change of 46.26% compared to the average of 1.80B of the last 4 quarters.

Chinook Therapeutics, Inc. (KDNY) Historical Enterprise Value (quarterly & annually)

How has KDNY Enterprise Value performed in the past?

The mean historical Enterprise Value of Chinook Therapeutics, Inc. over the last ten years is 1.72T. The current 2.63B Enterprise Value has changed -84.72% with respect to the historical average. Over the past ten years (40 quarters), KDNY's Enterprise Value was at its highest in in the June 2015 quarter at 7.98T. The Enterprise Value was at its lowest in in the December 2017 quarter at -157614000.00.

Chinook Therapeutics, Inc. (KDNY) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Chinook Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Chinook Therapeutics, Inc. (KDNY) Average Enterprise Value

How has KDNY Enterprise Value performed in the past?

The current Enterprise Value of Chinook Therapeutics, Inc. (KDNY) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Chinook Therapeutics, Inc. (KDNY) Enterprise Value vs. Peers

How is KDNY’s Enterprise Value compared to its peers?

Chinook Therapeutics, Inc.’s Enterprise Value is greater than DICE Therapeutics, Inc. (1.82B), greater than Pliant Therapeutics, Inc. (770.48M), less than Crinetics Pharmaceuticals, Inc. (4.93B), less than Ascendis Pharma A/S (7.61B), greater than Ventyx Biosciences, Inc. (80.09M), less than Nuvalent, Inc. (6.38B), less than Cerevel Therapeutics Holdings, Inc. (8.24B), greater than Travere Therapeutics, Inc. (1.95B), greater than Structure Therapeutics Inc. (1.75B), less than Avidity Biosciences, Inc. (4.80B), less than Revolution Medicines, Inc. (9.43B), greater than Day One Biopharmaceuticals, Inc. (963.46M), less than SpringWorks Therapeutics, Inc. (2.83B), less than Arcellx, Inc. (4.79B), less than Vaxcyte, Inc. (10.01B), greater than Viridian Therapeutics, Inc. (1.42B), greater than KalVista Pharmaceuticals, Inc. (468.87M), greater than Theseus Pharmaceuticals, Inc. (138.26M), greater than Kura Oncology, Inc. (807.00M),

Build a custom stock screener for Chinook Therapeutics, Inc. (KDNY) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Chinook Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Chinook Therapeutics, Inc. (KDNY) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Chinook Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.